HR 7537
Infectious Disease Therapies Research and Innovation Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Infectious Disease Therapies Research and Innovation Act of 2020, modifies tax rules to encourage investment in small businesses engaged in medical research. Specifically, it exempts certain medical research activities conducted by these small businesses from passive loss rules, allowing taxpayers to deduct losses related to these activities. It also clarifies definitions and ensures that these small businesses can fully utilize research and development deductions and credits, even when claimed through a pass-through entity.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.